Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1154-1159

  Kaya, Mehmet G ^a   Akpek, Mahmut ^a   Lam, Yat Yin ^b   Yarlioglues, Mikail ^a   Celik, Turgay ^c   Gunebakmaz, Ozgur ^a   Duran, Mustafa ^a   Ulucan, Seref ^d   Keser, Ahmet ^d   Oguzhan, Abdurrahman ^a   Gibson, Michael C ^e  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d MEVLANA UNIVERSITY   (Turkey)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Long term mortality; Neutrophil lymphocyte ratio; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ADULT; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE COURSE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

LONG-TERM MORTALITY; NEUTROPHIL/LYMPHOCYTE RATIO; PRIMARY PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84885320185     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.074     Document Type: Article

References (23)

1. Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;4:486-91.
2. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011;1:334-41.
3. Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with st-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;110:621-7.
4. Núñez J, Núñez E, Bodí V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008;6:747-52.
5. Shen XH, Chen Q, Shi Y, Li HW. Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Chin Med J (Engl) 2010;23:3438-43.
6. Niccoli G, Lanza GA, Spaziani C, et al. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol 2007;3:306-11.
7. LangRM, BierigM,Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;2:79-108.
8. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;9:1135-43.
9. Kaya MG, Yarlioglues M, Gunebakmaz O, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010;209: 278-82.
10. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 1981;13:573-9.
11. Avanzas P, Quiles J, Lopez dS, et al. Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol 2004;97:155-6.
12. Jala VR, Haribabu B. Leukotrienes and atherosclerosis: new roles for old mediators. Trends Immunol 2004;25:315-22.
13. Ricevuti G, Mazzone A, De Servi S, Specchia G, Fratino P. New trends in coronary artery disease: the role of granulocyte activation. Atherosclerosis 1989;78:261-5.
14. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 2004;44:1945-56.
15. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
16. Blum A, Sclarovsky S, Rehavia E, Shohat B. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acutemyocardial infarction. Am Heart J 1994;127:1226-30.
17. Widmer A, Linka AZ, AttenhoferJost CH, et al. Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiology 2003;99:25-31.
18. Dragu R, Huri S, Zuckerman R, et al. Predictive value of white blood cell subtypes or long-term outcome followingmyocardial infarction. Atherosclerosis 2008;196:405-12.
19. Horne BD, Anderson JL, John JM, et al. Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-43.
20. KayaMG, AkpekM, Elcik D, et al. Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers. Am J Cardiol 2012;6:851-5.
21. Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology 2012;63:213-7.
22. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008;1-2:27-31.
23. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-termmortality after percutaneous coronary intervention. Am J Cardiol 2006;7:993-6.